0001968822-25-000002.txt : 20250923 0001968822-25-000002.hdr.sgml : 20250923 20250923142103 ACCESSION NUMBER: 0001968822-25-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20250923 DATE AS OF CHANGE: 20250923 EFFECTIVENESS DATE: 20250923 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Volastra Therapeutics, Inc. CENTRAL INDEX KEY: 0001968822 ORGANIZATION NAME: EIN: 841816753 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-558375 FILM NUMBER: 251332974 BUSINESS ADDRESS: STREET 1: 1361 AMSTERDAM AVENUE STREET 2: SUITE 520 CITY: NEW YORK STATE: NY ZIP: 10027 BUSINESS PHONE: 646-344-1248 MAIL ADDRESS: STREET 1: 1361 AMSTERDAM AVENUE STREET 2: SUITE 520 CITY: NEW YORK STATE: NY ZIP: 10027 D 1 primary_doc.xml X0708 D LIVE 0001968822 Volastra Therapeutics, Inc. 1361 AMSTERDAM AVENUE SUITE 520 NEW YORK NY NEW YORK 10027 646-344-1248 DELAWARE None None Corporation true Ellie McGuire 1361 AMSTERDAM AVENUE SUITE 520 NEW YORK NY NEW YORK 10027 Director Jill Goldstein 1361 AMSTERDAM AVENUE SUITE 520 NEW YORK NY NEW YORK 10027 Director Luc Dochez 1361 AMSTERDAM AVENUE SUITE 520 NEW YORK NY NEW YORK 10027 Director Arjun Balar 1361 AMSTERDAM AVENUE SUITE 520 NEW YORK NY NEW YORK 10027 Director Samuel Bakhoum 1361 AMSTERDAM AVENUE SUITE 520 NEW YORK NY NEW YORK 10027 Director David Southwell 1361 AMSTERDAM AVENUE SUITE 520 NEW YORK NY NEW YORK 10027 Executive Officer Director David Nicholson 1361 AMSTERDAM AVENUE SUITE 520 NEW YORK NY NEW YORK 10027 Director Sandra Peterson 1361 AMSTERDAM AVENUE SUITE 520 NEW YORK NY NEW YORK 10027 Director Robert Mittendorff 1361 AMSTERDAM AVENUE SUITE 520 NEW YORK NY NEW YORK 10027 Director Pharmaceuticals Decline to Disclose 06b false 2025-09-08 false true false 0 30099998 30099998 0 false 11 0 0 0 false Volastra Therapeutics, Inc. /s/ David Southwell David Southwell Chief Executive Officer 2025-09-23